Tur-Kaspa, Ran

Publishing since 1978 (Dinosaur)

Has published 136 publications in 32 years

Number of publications published per year by Tur-Kaspa, Ran. (Source : PubMed)

Distribution of publications types for Tur-Kaspa, Ran. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Katz LH, Paul M, Guy DG, Tur-Kaspa R. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.  Transplant infectious disease : an official journal of the Transplantation Society  2009  
•  Hazzan R, Tur-Kaspa R. Bezafibrate Treatment of Primary Biliary Cirrhosis Following Incomplete Response to Ursodeoxycholic Acid.  J. Clin. Gastroenterol.  2009  
•  Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R. Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells.  Liver Int.  2009;29;9  
•  Cao W, Sun B, Feitelson MA, Wu T, Tur-Kaspa R, Fan Q. Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.  Int. J. Cancer  2009;124;12  
•  Rotman Y, Katz L, Cohen M, Cohen-Ezra O, Manhaim V, Braun M, Ben-Ari Z, Tur-Kaspa R. Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.  J. Viral Hepat.  2009;16;5  
•  Braun MM, Bar-Nathan N, Shaharabani E, Aizner S, Tur-Kaspa R, Belenky A, Mor E, Ben-Ari ZZ. Postshunt hepatic encephalopathy in liver transplant recipients.  Transplantation  2009;87;5  
•  Sikuler E, Tur-Kaspa R, Shemer-Avni Y, Delgado J, Zilberman D, Fich A, Baruch Y, Hyam E. Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.  J. Clin. Gastroenterol.  2008;42;6  
•  Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, Barak N, Rotman Y, Cohen M, Waked A, Tur-Kaspa R, Ben-Ari Z. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis.  J. Clin. Gastroenterol.  2008;42;4  
•  Trahtenherts A, Gal-Tanamy M, Zemel R, Bachmatov L, Loewenstein S, Tur-Kaspa R, Benhar I. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.  Antiviral Res.  2008;77;3  
•  Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.  J. Viral Hepat.  2008;15;2  

[ See timeline ] [ See all publications ]